
NHS to pay 25% more for innovative drugs after UK–US zero-tariff deal
Agreement could cost NHS an extra £3bn a year, industry sources estimate
The Guardian
NHS to pay 25% more for innovative drugs after UK–US zero-tariff deal
Agreement could cost NHS an extra £3bn a year, industry sources estimate
The Guardian
Judge to approve $7bn settlement with OxyContin maker that requires Sackler family members to pay victims
Deal would also require multibillionaire family to give up ownership of the Connecticut-based firm
The Guardian
Antidepressants are trendy. That’s a double-edged sword
It’s great the taboo is fading. But as TikTok influencers tout them, it’s a slippery slope to the memeification of disorders
The Guardian
Top FDA official quits amid inquiry into ‘serious concerns’ over his conduct
Lawsuit claims George Tidmarsh, head of FDA drug center, waged personal vendetta against pharmaceutical executive
The Guardian‘Patients will suffer’: tales from the frontline of the UK pharma crisis
The pricing standoff between government and industry has stalled research and put thousands of jobs at risk
The GuardianWegovy maker Novo Nordisk’s chair and six other board members step down
Surprise shake-up follows row with majority shareholder, which seeks ‘extensive reconfiguration’
The GuardianThousands in UK take legal action against Johnson & Johnson over alleged talc cancer link
High court claim says company knowingly sold product containing asbestos and ‘concealed’ risk to public
The GuardianAstraZeneca makes deal with Trump to lower drug prices and avoid tariffs
Company will sell some medicines at a discount to government’s Medicaid health plan in exchange for tariff relief
The GuardianNHS could pay 25% more for medicines under plan to end row with drugmakers and Trump
UK ministers preparing to raise payments to end standoff with pharma industry, cited as reason for firms axing British investments
The Guardian